Jinxia Liu

7PUBLICATIONS
10CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 09, 2026
Oxytocin Attenuates Metabolic Dysfunction-associated Steatotic Liver Disease via AMPK/SREBP1c/FAS-mediated Suppression of Hepatic Lipogenesis.

Yue Xu, Siqian Lu, Hongpei Wu

|Jan 06, 2024
The upregulation of Annexin A2 by TLR4 pathway facilitates lipid accumulation and liver injury via blocking AMPK/mTOR-mediated autophagy flux during the development of non-alcoholic fatty liver disease.

Haifeng Wu, Meng Zhou, Qin Jin

|Feb 01, 2020
Ubiquitin-specific protease 7 is a drug-able target that promotes hepatocellular carcinoma and chemoresistance.

Wei Zhang, Jingxin Zhang, Chenzhou Xu

|Mar 30, 2019
MKP-4 suppresses hepatocarcinogenesis by targeting ERK1/2 pathway.

Zhongyi Shen, Chengliang Zhang, Lishuai Qu

|Nov 17, 2018
Coupling function of cyclin-dependent kinase 2 and Septin2 in the promotion of hepatocellular carcinoma.

Chenzhou Xu, Wei Zhang, Xuening Zhang

|Oct 12, 2018
β2-AR regulates the expression of AKR1B1 in human pancreatic cancer cells and promotes their proliferation via the ERK1/2 pathway.

Ming-Bing Xiao, Dan-Dan Jin, Yu-Jie Jiao

Pageof 2

Frequent Collaborators

2 joint publications

Cuihua Lu

1 joint publications

Ming-Bing Xiao

1 joint publications

Dan-Dan Jin

1 joint publications

Yu-Jie Jiao